Amarin reported $164.07M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
Amarin USD 164.07M 19.51M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
Novartis USD 6.22B 66M Jun/2026